D&D Pharmatech Inc. (KOSDAQ:347850)
South Korea · Delayed Price · Currency is KRW 78,100
-800 (-1.01%)
At close: Mar 20, 2026
D&D Pharmatech Market Cap
D&D Pharmatech has a market cap or net worth of 3.4 trillion as of March 20, 2026. Its market cap has increased by 474.53% in one year.
Market Cap
3.40T
Enterprise Value
3.37T
Revenue
8.36B
Ranking
n/a
PE Ratio
n/a
Stock Price
78,100.00
Market Cap Chart
Since May 2, 2024, D&D Pharmatech's market cap has increased from 379.56B to 3.40T, an increase of 795.80%. That is a compound annual growth rate of 220.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 3.40T | -14.92% |
| Dec 30, 2025 | 4.00T | 678.13% |
| Dec 30, 2024 | 513.61B | 35.32% |
| May 2, 2024 | 379.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Peptron | 8.07T |
| LigaChem Biosciences | 7.75T |
| SK Biopharmaceuticals | 7.72T |
| HLB Co., Ltd. | 6.87T |
| Voronoi | 5.76T |
| OliX Pharmaceuticals | 3.77T |
| PharmaResearch | 3.38T |
| SK bioscience | 3.36T |